Literature DB >> 16749860

Influence of charge and steric bulk in the C-24 region on the interaction of bile acids with human apical sodium-dependent bile acid transporter.

Anand Balakrishnan1, Stephen A Wring, Andrew Coop, James E Polli.   

Abstract

The human apical sodium-dependent bile acid transporter (hASBT) is a potential target for drug delivery, but an understanding of hASBT substrate requirements is limited. The objective of this study was to evaluate the influence of ionic character and steric bulk in the C-24 region of bile acid conjugates in governing interaction with hASBT. Ionic character was studied using chenodeoxycholate (CDCA) conjugates of glutamic acid and lysine, which varied in charge (monoanionic, dianionic, cationic, neutral, and zwitterionic) and location of charge (proximal or distal to C-24). Steric effects were evaluated using ester conjugates that varied in ester substituent size (methyl, benzyl, and tert-butyl) and location (proximal and/or distal). Conjugate interaction with hASBT was assessed via transport and inhibition studies, using a hASBT-MDCK monolayer. Monoanionic, cationic, and neutral conjugates of CDCA exhibited high inhibitory potency (Ki<10 microM). High inhibition potency of neutral and cationic conjugates indicated that a negative charge is not essential for hASBT binding. Dianionic conjugates exhibited low inhibition potency (Ki>100 microM). Conjugates with a single bulky ester substituent proximal or distal to the C-24 region exhibited high inhibition potency. However, two bulky substituents practically abolished interaction. In transport studies, monoanionic conjugates were high affinity hASBT substrates. Meanwhile, cationic and zwitterionic conjugates were not substrates for hASBT. Overall, C-24 ionic character influenced interaction with hASBT. Although the presence of a single negative charge was not essential for interaction with hASBT, monoanionic conjugates were favored for hASBT-mediated transport compared to cationic and zwitterionic conjugates.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16749860      PMCID: PMC2526283          DOI: 10.1021/mp0600135

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  16 in total

1.  Chlorambucil-taurocholate is transported by bile acid carriers expressed in human hepatocellular carcinomas.

Authors:  G A Kullak-Ublick; J Glasa; C Böker; M Oswald; U Grützner; B Hagenbuch; B Stieger; P J Meier; U Beuers; W Kramer; G Wess; G Paumgartner
Journal:  Gastroenterology       Date:  1997-10       Impact factor: 22.682

Review 2.  Bile acid transport systems as pharmaceutical targets.

Authors:  W Kramer; G Wess
Journal:  Eur J Clin Invest       Date:  1996-09       Impact factor: 4.686

3.  Enhanced transepithelial transport of peptides by conjugation to cholic acid.

Authors:  P W Swaan; K M Hillgren; F C Szoka; S Oie
Journal:  Bioconjug Chem       Date:  1997 Jul-Aug       Impact factor: 4.774

4.  Influence of passive permeability on apparent P-glycoprotein kinetics.

Authors:  K A Lentz; J W Polli; S A Wring; J E Humphreys; J E Polli
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

5.  Interaction of native bile acids with human apical sodium-dependent bile acid transporter (hASBT): influence of steroidal hydroxylation pattern and C-24 conjugation.

Authors:  Anand Balakrishnan; Stephen A Wring; James E Polli
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.200

6.  Topology scanning and putative three-dimensional structure of the extracellular binding domains of the apical sodium-dependent bile acid transporter (SLC10A2).

Authors:  Eric Y Zhang; Mitch A Phelps; Antara Banerjee; Chandra M Khantwal; Cheng Chang; Freek Helsper; Peter W Swaan
Journal:  Biochemistry       Date:  2004-09-14       Impact factor: 3.162

Review 7.  The sodium bile salt cotransport family SLC10.

Authors:  Bruno Hagenbuch; Paul Dawson
Journal:  Pflugers Arch       Date:  2003-07-08       Impact factor: 3.657

8.  Synthesis and biological activity of bile acid-derived HMG-CoA reductase inhibitors. The role of 21-methyl in recognition of HMG-CoA reductase and the ileal bile acid transport system.

Authors:  G Wess; W Kramer; X B Han; K Bock; A Enhsen; H Glombik; K H Baringhaus; G Böger; M Urmann; A Hoffmann
Journal:  J Med Chem       Date:  1994-09-30       Impact factor: 7.446

9.  Bile acid derived HMG-CoA reductase inhibitors.

Authors:  W Kramer; G Wess; A Enhsen; K Bock; E Falk; A Hoffmann; G Neckermann; D Gantz; S Schulz; L Nickau
Journal:  Biochim Biophys Acta       Date:  1994-11-29

10.  Properties and biological significance of the ileal bile salt transport system.

Authors:  L Lack
Journal:  Environ Health Perspect       Date:  1979-12       Impact factor: 9.031

View more
  12 in total

1.  Molecular switch controlling the binding of anionic bile acid conjugates to human apical sodium-dependent bile acid transporter.

Authors:  Rana Rais; Chayan Acharya; Gasirat Tririya; Alexander D Mackerell; James E Polli
Journal:  J Med Chem       Date:  2010-06-24       Impact factor: 7.446

2.  Impact of impurity on kinetic estimates from transport and inhibition studies.

Authors:  Pablo González; James E Polli
Journal:  J Pharmacol Exp Ther       Date:  2008-04-28       Impact factor: 4.030

3.  Structural requirements of bile acid transporters: C-3 and C-7 modifications of steroidal hydroxyl groups.

Authors:  Vidula Kolhatkar; James E Polli
Journal:  Eur J Pharm Sci       Date:  2012-03-03       Impact factor: 4.384

4.  Structural requirements of the ASBT by 3D-QSAR analysis using aminopyridine conjugates of chenodeoxycholic acid.

Authors:  Xiaowan Zheng; Yongmei Pan; Chayan Acharya; Peter W Swaan; James E Polli
Journal:  Bioconjug Chem       Date:  2010-10-22       Impact factor: 4.774

5.  A novel bioluminescence-based method to investigate uptake of bile acids in living cells.

Authors:  Alexander L Ticho; Hyunjin Lee; Ravinder K Gill; Pradeep K Dudeja; Seema Saksena; Daesung Lee; Waddah A Alrefai
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-06-21       Impact factor: 4.052

6.  Structural determinants for transport across the intestinal bile acid transporter using C-24 bile acid conjugates.

Authors:  Rana Rais; Chayan Acharya; Alexander D Mackerell; James E Polli
Journal:  Mol Pharm       Date:  2010-11-01       Impact factor: 4.939

7.  Inhibition requirements of the human apical sodium-dependent bile acid transporter (hASBT) using aminopiperidine conjugates of glutamyl-bile acids.

Authors:  Pablo M González; Chayan Acharya; Alexander D Mackerell; James E Polli
Journal:  Pharm Res       Date:  2009-04-21       Impact factor: 4.200

8.  Method to screen substrates of apical sodium-dependent bile acid transporter.

Authors:  Rana Rais; Pablo M Gonzalez; Xiaowan Zheng; Stephen A Wring; James E Polli
Journal:  AAPS J       Date:  2008-12-16       Impact factor: 4.009

9.  Synthesis and in vitro evaluation of bile acid prodrugs of floxuridine to target the liver.

Authors:  Diana Vivian; James E Polli
Journal:  Int J Pharm       Date:  2014-09-16       Impact factor: 5.875

10.  Conserved aspartic acid residues lining the extracellular loop 1 of sodium-coupled bile acid transporter ASBT Interact with Na+ and 7alpha-OH moieties on the ligand cholestane skeleton.

Authors:  Naissan Hussainzada; Tatiana Claro Da Silva; Eric Y Zhang; Peter W Swaan
Journal:  J Biol Chem       Date:  2008-05-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.